{"entities": {"mentions": [{"start": 0, "end": 14, "username": "morethanmySLE", "id": "812361923304034304"}, {"start": 15, "end": 23, "username": "jdginlr", "id": "541238516"}], "urls": [{"start": 176, "end": 199, "url": "https://t.co/ZeLLSXzRs1", "expanded_url": "https://theintercept.com/2020/03/23/gilead-sciences-coronavirus-treatment-orphan-drug-status/", "display_url": "theintercept.com/2020/03/23/gil\u2026"}]}, "referenced_tweets": [{"type": "replied_to", "id": "1247350666034544642"}], "context_annotations": [{"domain": {"id": "65", "name": "Interests and Hobbies Vertical", "description": "Top level interests and hobbies groupings, like Food or Travel"}, "entity": {"id": "781974596148793345", "name": "Business & finance"}}, {"domain": {"id": "66", "name": "Interests and Hobbies Category", "description": "A grouping of interests and hobbies entities, like Novelty Food or Destinations"}, "entity": {"id": "857878402157629440", "name": "Investors and patents", "description": "Investors and patents"}}], "public_metrics": {"retweet_count": 1, "reply_count": 2, "like_count": 1, "quote_count": 0}, "in_reply_to_user_id": "812361923304034304", "lang": "en", "conversation_id": "1247350666034544642", "created_at": "2020-04-07T23:52:37.000Z", "text": "@morethanmySLE @jdginlr Worse than that, why promote a $1.00 / day drug with no exclusive patents?\n\nHell, he should have waited! A lot more to be made with Gilead's new drug!\n\nhttps://t.co/ZeLLSXzRs1", "reply_settings": "everyone", "author_id": "945808554480537600", "source": "Twitter for Android", "possibly_sensitive": false, "id": "1247673668592943105"}